Detalhe da pesquisa
1.
High expression of AlkB homolog 5 suppresses the progression of non-small cell lung cancer by facilitating ferroptosis through m6A demethylation of SLC7A11.
Environ Toxicol
; 39(7): 4035-4046, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38642004
2.
Efficacy and safety of fluzoparib combined with anlotinib in extensive stage small cell lung cancer after first-line platinum-based chemotherapy: a multi-center, single-arm prospective phase II clinical study (STAMP study).
BMC Cancer
; 23(1): 753, 2023 Aug 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37580661
3.
Effects of intrathecal pemetrexed on the survival of patients with leptomeningeal metastasis from lung adenocarcinoma: a propensity score matching analysis.
J Neurooncol
; 165(2): 301-312, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37995007
4.
The deep learning model combining CT image and clinicopathological information for predicting ALK fusion status and response to ALK-TKI therapy in non-small cell lung cancer patients.
Eur J Nucl Med Mol Imaging
; 48(2): 361-371, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32794105
5.
Ginsenoside compound K inhibits growth of lung cancer cells via HIF-1α-mediated glucose metabolism.
Cell Mol Biol (Noisy-le-grand)
; 65(4): 48-52, 2019 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31078152
6.
Knockdown of circ-RAD23B inhibits non-small cell lung cancer progression via the miR-142-3p/MAP4K3 axis.
Thorac Cancer
; 13(5): 750-760, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35106926
7.
Vinpocetine enhances cisplatin sensitivity of non-small cell lung cancer cells by reducing the nuclear factor erythroid 2-related factor 2 signaling.
J Investig Med
; 70(6): 1358-1364, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35580917
8.
Efficacy and Safety of Sintilimab Plus Anlotinib for PD-L1-Positive Recurrent or Metastatic Cervical Cancer: A Multicenter, Single-Arm, Prospective Phase II Trial.
J Clin Oncol
; 40(16): 1795-1805, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35192397
9.
Prognostic Value of the Lung Immune Prognostic Index May Differ in Patients Treated With Immune Checkpoint Inhibitor Monotherapy or Combined With Chemotherapy for Non-small Cell Lung Cancer.
Front Oncol
; 10: 572853, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33163403
10.
[Efficacy of S-1 in Advanced Non-small Cell Lung Cancer Patients Treated â©with More Than Two Lines of Chemotherapy].
Zhongguo Fei Ai Za Zhi
; 21(6): 437-444, 2018 Jun 20.
Artigo
em Zh
| MEDLINE | ID: mdl-29945701
11.
The Tumor Mutational Burden of Chinese Advanced Cancer Patients Estimated by a 381-cancer-gene Panel.
J Cancer
; 9(13): 2302-2307, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30026825
12.
TP53 mutations predict for poor survival in ALK rearrangement lung adenocarcinoma patients treated with crizotinib.
J Thorac Dis
; 10(5): 2991-2998, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29997966